ABSTRACT:
Pregnancy-related medication use is widespread, but it can be clinically challenging because of physiological changes, altered drug metabolism, and a lack of safety data. This research focuses on India and looks at teratogenic risks, pharmacological considerations, and common drug classes used during pregnancy. The high prevalence of essential supplements (92%) and low-dose aspirin (90%) in Sambhajinagar, as reported by a community-based survey, indicates adherence to current pre-eclampsia prevention guidelines. New digital solutions are enhancing medication safety, counseling, and monitoring, especially in rural and low-resource settings. Examples of these include artificial intelligence (AI) and mobile health (mHealth) platforms like GynoSakhi, mMitra, and SwasthGarbh.One possible approach to providing holistic maternal care is the combination of evidence-based medication and traditional Ayurvedic treatments. Pregnant women must be ethically included in clinical trials, digital tools must be validated, and continuous research is necessary to ensure safe, customized care.
Cite this article:
Payal Sonawane, Aishwarya Tare, Prerna Tarak, Dr. Nilima N. Khakal, Dr. S. S. Angad. Medication Used in Pregnancy. IJRPAS, October 2025; 4(10): 50-65.DOI: https://doi.org/https://doi.org/10.71431/IJRPAS.2025.41004
REFERENCES:
1.
1.Andrade SE, Gurwitz JH, Davis RL, et al.
Prescription drug use in pregnancy. Am J Obstet Gynecol. 2004;191(2):398–407.
doi:10.1016/j.ajog.2004.04.025
2.
Daw JR, Hanley GE, Greyson DL, Morgan SG.
Prescription drug use during pregnancy in developed countries: a systematic
review. Pharmacoepidemiol Drug Saf. 2011;20(9):895–902. doi:10.1002/pds.2178
3.
Ramakrishnan A, et al. mHealth interventions
in maternal and child health: Evidence from India. BMC Pregnancy Childbirth.
2020;20:1–14. doi:10.1186/s12884-020-03163-5
4.
Ministry of Health and Family Welfare, India.
National Health Mission: Maternal Health Programmes. New Delhi: MoHFW; 2022.
ISBN: 978-81-232-5312-8
5.
American College of Obstetricians and
Gynecologists. Practice Bulletin No. 202: Management of Hypertension in
Pregnancy. Obstet Gynecol. 2019;133:e237–e256. doi:10.1097/AOG.0000000000003126
6.
Mitra A, Swain S, Raut A, et al. Low-dose
aspirin for pre-eclampsia prevention in India: A review of recent evidence. Indian
J Obstet Gynecol Res. 2021;8(3):145–152. doi:10.18231/j.ijogr.2021.032
7.
American College of Obstetricians and
Gynecologists. Low-dose aspirin use during pregnancy. Committee Opinion No.
743. Obstet Gynecol. 2018;132:e44–e52. Available from: https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2018/07/low-dose-aspirin-use-during-pregnancy
8.
Preeclampsia Foundation. Aspirin in
pregnancy: benefits and risks. 2023. Available from: https://www.preeclampsia.org/aspirin
9.
Right Decisions, NHS Scotland. Low-dose
aspirin in pregnancy: guidance for healthcare professionals. 2024. Available
from: https://rightdecisions.scot.nhs.uk/media/oibbvkom/low-dose-aspirin-in-pregnancy-february-2024.pdf
10.
Hossain M, Rahman M, Islam M. Artificial
intelligence in maternal and child health: a review. J Pregnancy Child Health.
2025;12:45–56. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12270093/
11.
Zhang Y, Li X, Chen J. Machine learning
models for predicting drug safety during pregnancy. Open J Med Data.
2024;8:115–128. Available from: https://www.scirp.org/journal/paperinformation?paperid=143241
12.
University of Birmingham. AI-related maternal
healthcare software improves odds of good care by 69%, research finds. 2024.
Available from: https://www.birmingham.ac.uk/news/2024/ai-related-maternal-healthcare-software-improves-odds-of-good-care-by-69-research-finds
13.
Chan K, Cheung S, Lee A. Herbal medicine use
in pregnancy and risk of birth defects: a systematic review. J Ethnopharmacol.
2024;305:115774. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0944711324008547
14.
Ask Ayurveda. Safe Ayurvedic medicine during
pregnancy for mother & baby wellness. 2023. Available from: https://ask-ayurveda.com/articles/402-safe-ayurvedic-medicine-during-pregnancy-for-mother--baby-wellness
15.
Wang L, Liu Y, Zhou X. Herbal medicine
consumption among Chinese mothers during pregnancy and postpartum. BMC
Complement Med Ther. 2023;23:88. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12440907/
16.
Roberge S, Bujold E, Nicolaides KH. Low-dose
aspirin at ≤16 weeks of gestation for preventing pre-eclampsia and its maternal
and neonatal adverse outcomes: systematic review and meta-analysis. Am J Obstet
Gynecol. 2018;218(1):95–106.
17.
Xu J, Li P, Zhao M, et al. Optimal dosage of
aspirin for preventing pre-eclampsia in high-risk pregnant women: network
meta-analysis of 23 randomized controlled trials. BMJ Open. 2023;13:e073641.
18.
Chen L, Wang Y, Gao Y, et al. Effect of
low-dose aspirin on pregnancy outcomes: a systematic review and meta-analysis
of randomized trials. Front Pharmacol. 2024;15:1345126.
19.
Roberge S, Demers S, Bujold E. The role of
aspirin dose on prevention of pre-eclampsia and fetal growth restriction:
systematic review and meta-analysis. Obstet Gynecol. 2016;127(4):727–734.
20.
Bujold E, Roberge S, Lacasse Y, et al.
Prevention of pre-eclampsia and intrauterine growth restriction with aspirin
started in early pregnancy: meta-analysis. Obstet Gynecol. 2010;116(2 Pt
1):402–414.
21.
Rajput N, Kaur R, Dey A. Artificial
intelligence in maternal health: opportunities and challenges in India. J
Family Med Prim Care. 2023;12(8):1354–1360.
22.
Sharma P, Gupta R, Malhotra B, et al. Digital
and mobile health innovations for maternal and child health in India: current
landscape and future potential. Indian J Public Health. 2022;66(2):124–130.
23.
Verma S, Gupta A, Bansal A. GynoSakhi:
AI-IoT-enabled platform for pregnancy monitoring and medication adherence in
Indian settings. Health Technol (Berl). 2023;13(5):987–996.
24.
Sinha A, Rao P, Ghosh R. Implementation of
AI-driven chatbots for antenatal care counseling in rural India: a pilot
evaluation. BMC Pregnancy Childbirth. 2024;24(1):512.
25.
Agarwal A, Sharma S, Yadav S, et al.
SwasthGarbh: An AI-enabled mobile app for maternal and fetal
monitoring—development and usability testing. BMJ Innov. 2023;9(3):172–179.
26.
ARMMAN Foundation. mMitra voice messaging
program improves maternal health knowledge and practices in low-resource
settings. Public Health Action. 2022;12(1):45–50.